Education, Science, Technology, Innovation and Life
Open Access
Sign In

Endocrine Abnormalities and Their Relationship with Menstrual Irregularities: A Meta-analysis

Download as PDF

DOI: 10.23977/phpm.2024.040208 | Downloads: 1 | Views: 49

Author(s)

Xinyu Qi 1

Affiliation(s)

1 Taizhou University, Taizhou, Zhejiang Province, 318000, China

Corresponding Author

Xinyu Qi

ABSTRACT

The endocrine system is one of the important systems that maintain physiological balance in the human body, and its abnormalities are closely related to the occurrence of various diseases, especially irregular menstruation in women. Irregular menstruation not only affects women's quality of life, but also has a negative impact on fertility. Therefore, exploring the relationship between endocrine abnormalities and menstrual irregularities has important clinical significance. Although numerous studies have explored the relationship between endocrine abnormalities and menstrual irregularities, the conclusions are inconsistent. This article systematically evaluated the degree of association between endocrine disorders and menstrual irregularities through meta-analysis. Firstly, the background knowledge of endocrine disorders and menstrual irregularities is introduced, and then the progress and shortcomings of related research are reviewed. Next, the research method, experimental investigation results, and discussion of this article were introduced in detail. Through meta-analysis, this article found a significant correlation between endocrine abnormalities and menstrual irregularities.

KEYWORDS

Endocrine Disorders, Menstrual Irregularities, Meta-Analysis Method, Abnormal Relationships

CITE THIS PAPER

Xinyu Qi, Endocrine Abnormalities and Their Relationship with Menstrual Irregularities: A Meta-analysis. MEDS Public Health and Preventive Medicine (2024) Vol. 4: 54-62. DOI: http://dx.doi.org/10.23977/phpm.2024.040208.

REFERENCES

[1] Vannuccini S, Clemenza S, Rossi M, et al. Hormonal treatments for endometriosis: The endocrine background[J]. Reviews in Endocrine and Metabolic Disorders, 2022, 23(3): 333-355.
[2] Rytz C L, Kochaksaraei G S, Skeith L, et al. Menstrual abnormalities and reproductive lifespan in females with CKD: a systematic review and meta-analysis[J]. Clinical Journal of the American Society of Nephrology, 2022, 17(12): 1742-1753.
[3] Tsukui Y, Kitahara Y, Hasegawa Y, et al. Anti-Müllerian hormone levels in the diagnosis of adolescent polycystic ovarian syndrome: a systematic review and meta-analysis[J]. Endocrine Journal, 2022, 69(8): 897-906.
[4] Uldbjerg C S, Koch T, Lim Y H, et al. Prenatal and postnatal exposures to endocrine disrupting chemicals and timing of pubertal onset in girls and boys: a systematic review and meta-analysis[J]. Human Reproduction Update, 2022, 28(5): 687-716. 
[5] Cho I Y, Chang Y, Kang J H, et al. Long or irregular menstrual cycles and risk of prevalent and incident nonalcoholic fatty liver disease[J]. The Journal of Clinical Endocrinology & Metabolism, 2022, 107(6): e2309-e2317.
[6] Forslund M, Melin J, Alesi S, et al. Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis[J]. European journal of endocrinology, 2023, 189(1): S1-S16.
[7] Li Z, Wang Y H, Wang L L, et al. Polycystic ovary syndrome and the risk of endometrial, ovarian and breast cancer: An updated meta-analysis[J]. Scottish Medical Journal, 2022, 67(3): 109-120.
[8] Amiri M, Fallahzadeh A, Sheidaei A, et al. Prevalence of idiopathic hirsutism: A systematic review and meta‐analysis [J]. Journal of Cosmetic Dermatology, 2022, 21(4): 1419-1427.
[9] Ezeh U, Pisarska M D, Azziz R. Association of severity of menstrual dysfunction with hyperinsulinemia and dysglycemia in polycystic ovary syndrome[J]. Human Reproduction, 2022, 37(3): 553-564.
[10] Sharma P, Gupta V, Kumar K, et al. Assessment of serum elements concentration and polycystic ovary syndrome (PCOS): systematic review and meta-analysis[J]. Biological Trace Element Research, 2022, 200(11): 4582-4593.
[11] Johnson J E, Daley D, Tarta C, et al. Risk of endometrial cancer in patients with polycystic ovarian syndrome: A meta-analysis[J]. Oncology Letters, 2023, 25(4): 1-9.
[12] Bayona A, Martinez-Vaello V, Zamora J, et al. Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis[J]. Human reproduction update, 2022, 28(4): 501-517.
[13] Lu M Y, Niu J L, Liu B. The risk of endometriosis by early menarche is recently increased: a meta-analysis of literature published from 2000 to 2020[J]. Archives of Gynecology and Obstetrics, 2023, 307(1): 59-69.
[14] Shan D, Han J, Cai Y, et al. Reproductive health in first-degree relatives of patients with polycystic ovary syndrome: a review and meta-analysis[J]. The Journal of Clinical Endocrinology & Metabolism, 2022, 107(1): 273-295.
[15] Zhou S, Lu D, Wen S, et al. Elevated anti-müllerian hormone levels in newborns of women with polycystic ovary syndrome: a systematic review and meta-analysis based on observational studies[J]. Reproductive Sciences, 2022, 29(1): 301-311.
[16] Millán-de-Meer M, Luque-Ramírez M, Nattero-Chávez L, et al. PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis[J]. Human reproduction update, 2023, 29(6): 741-772.
[17] Chatzakis C, Tsakmaki E, Psomiadou A, et al. Different pregnancy outcomes according to the polycystic ovary syndrome diagnostic criteria: a systematic review and meta-analysis of 79 studies[J]. Fertility and Sterility, 2022, 117(4): 854-881.
[18] Cioana M, Deng J, Nadarajah A, et al. Prevalence of polycystic ovary syndrome in patients with pediatric type 2 diabetes: a systematic review and meta-analysis[J]. JAMA network Open, 2022, 5(2): 214-215.
[19] Dobbie L J, Pittam B, Zhao S S, et al. Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis[J]. Human Reproduction, 2023, 38(6): 1168-1182.
[20] Yang S, Zhao L, He W, et al. The effect of oral antidiabetic drugs on improving the endocrine and metabolic states in women with polycystic ovary syndrome: a systematic review and network meta-analysis[J]. Drugs, 2022, 82(14): 1469-1480.

Downloads: 2579
Visits: 105145

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.